4 completed, 1 unknown. 5 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 4, Unknown 1 |
Follow SinoMab BioScience Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Study to Evaluate SM17 in Healthy Participants SM17, SM17 placebo - Atopic Dermatitis, Asthma | Phase 1 | Completed | SinoMab BioScience Ltd | 30 | 2025-10-14 | 2026-04-06 |
| A Phase I Clinical Study to Evaluate SM17 in Chinese Healthy Subjects and Patients With Moderate to Severe Atopic Dermatitis SM17 for injection, SM17 placebo for injection - Atopic Dermatitis | Phase 1 | Completed | SinoMab BioScience Ltd | 64 | 2023-11-21 | 2025-08-08 |
| A Phase 1 Study of Single and Multiple Intravenous Doses of SM17 in Healthy Subjects SM17, Placebo - Asthma | Phase 1 | Completed | SinoMab BioScience Ltd | 77 | 2022-06-14 | 2024-09-27 |
| A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Health Subject SN1011, SN1011 placebo - Autoimmune Diseases | Phase 1 | Unknown | SinoMab BioScience Ltd | 80 | 2019-08-27 | 2019-09-23 |
| A Study of the Pharmacokinetics and Safety of SM03 in Patients With Rheumatoid Arthritis Biological: SM03 - Rheumatoid Arthritis | Phase 1 | Completed | SinoMab BioScience Ltd | 8 | 2012-08-14 | 2021-01-11 |
Asthma (2) · Dermatitis, Atopic (2) · Arthritis, Rheumatoid (1) · Autoimmune Diseases (1) · Inflammatory Bowel Diseases (1)
Injections (1)
China (3) · Australia (1) · United States (1)
Pei Hu, PhD,MD (1) · Xin-Hua Gao, MD (1)